Personalized Sertraline Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Sertraline Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Personalized Escitalopram Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Escitalopram Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Personalized Sertraline Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Sertraline Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Personalized Escitalopram Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Escitalopram Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Personalized Sertraline Dosing in Patients With Depression
Condition: Depressive Disorder, Major Intervention: Drug: Sertraline Sponsors: University of Belgrade; Clinical Centre of Serbia; Institute of Mental Health, Serbia; Military Medical Academy, Belgrade, Serbia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials
Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer
Conditions: Chronic Limb-Threatening Ischemia; Colorectal Carcinoma; Colorectal Carcinoma Metastatic in the Liver Intervention: Procedure: For chronic limb-threatening ischemia (CLTI) patients revascularisation surgery; for colorectal liver metastasis (CRLM) patients metastatic liver surgery Sponsor: Clinical Centre of Serbia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials